Exhibit 99.1

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED

JUNE 30, 2023

(UNAUDITED)

 

1

 

 

INDEX TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023

(UNAUDITED)

 

Item

 

Page

Consolidated Balance Sheets

 

2

Consolidated Statements of Operations and Comprehensive Loss

 

3

Consolidated Statements of Changes in Equity

 

4-5

Consolidated Statements of Cash Flows

 

6

Notes to Condensed Consolidated Interim Financial Statements

 

7-20

1

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Balance Sheets      
(in thousands, except per share data)      
   June 30, 2023   December 31, 2022 
ASSETS      
Current assets      
Cash and cash equivalents $144,366  $150,470 
Short-term deposits  61,000   177,367 
Accounts receivable, net of allowance for credit losses of $0.8 million and $0.9 million as of June 30, 2023 and December 31, 2022, respectively  156,264   144,739 
Inventories  211,186   194,054 
Prepaid expenses  10,187   5,767 
Other current assets  27,463   27,823 
Total current assets  610,466   700,220 
Non-current assets      
Property, plant and equipment, net  200,994   195,063 
Goodwill  92,946   64,953 
Other intangible assets, net  148,613   121,402 
Operating lease right-of-use assets  20,513   18,122 
Long-term investments  138,624   141,610 
Other non-current assets  18,269   18,420 
Total non-current assets  619,959   559,570 
      
Total assets $1,230,425  $1,259,790 
      
LIABILITIES AND EQUITY      
Current liabilities      
Accounts payable  $69,793  $72,921 
Accrued expenses and other current liabilities  50,763   45,912 
Accrued compensation and related benefits   29,534   34,432 
Deferred revenues - short term  51,865   50,220 
Operating lease liabilities - short term  6,842   7,169 
Total current liabilities  208,797   210,654 
Non-current liabilities      
Deferred revenues - long term  27,399   25,214 
Deferred income taxes - long term  6,995   5,638 
Operating lease liabilities - long term  13,346   10,670 
Contingent consideration - long term  26,151   23,707 
Other non-current liabilities  24,510   24,475 
Total non-current liabilities  98,401   89,704 
      
Total liabilities $307,198  $300,358 
      
Contingencies (see note 13)  
   
 
      
Equity      
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 shares; 68,942 shares and 67,086 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively  193   187 
Additional paid-in capital  3,073,396   3,048,915 
Accumulated other comprehensive loss  (12,671  (12,818
Accumulated deficit  (2,137,691  (2,076,852
Total equity  923,227   959,432 
      
Total liabilities and equity $1,230,425  $1,259,790 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

2

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)


Consolidated Statements of Operations and Comprehensive Loss          
(in thousands, except per share data)          
    Three Months Ended June 30, Six Months Ended June 30,
    2023   2022   2023   2022 
          
Revenues              
Products   $109,112  $115,721  $210,083  $228,794 
Services    50,639   50,882   99,045   101,238 
    159,751   166,603   309,128   330,032 
Cost of revenues              
Products    57,576   61,132   108,689   120,505 
Services    35,953   38,078   68,822   72,457 
     93,529   99,210   177,511   192,962 
              
Gross profit    66,222   67,393   131,617   137,070 
          
Operating expenses              
Research and development, net    24,305   24,346   45,780   48,344 
Selling, general and administrative    75,576   66,592   136,293   131,855 
     99,881   90,938   182,073   180,199 
              
Operating loss    (33,659  (23,545  (50,456  (43,129
              
Financial income (expenses), net    687   (1,170  1,460   (2,532
              
Loss before income taxes    (32,972  (24,715  (48,996  (45,661
              
Income tax benefit (expenses)    (725  429   (4,500  502 
Share in losses of associated companies    (4,918  (99  (7,343  (174
              
Net loss   $(38,615 $(24,385 $(60,839 $(45,333
              
Net loss per share - basic and diluted
   $(0.56 $(0.37 $(0.89 $(0.69
Weighted average ordinary shares outstanding. - basic and diluted
    68,648   66,568   68,107   66,151 
          
Comprehensive loss              
Net loss    (38,615  (24,385  (60,839  (45,333
Other comprehensive income (loss), net of tax:              
Foreign currency translation adjustments    579   (2,789  1,834   (3,491
Unrealized gains (losses) on derivatives designated as cash flow hedges    558   (741  (1,687  (1,092
Other comprehensive income (loss), net of tax    1,137   (3,530  147   (4,583
              
Comprehensive loss   $(37,478 $(27,915 $(60,692 $(49,916

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

3

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Changes in Equity            
(in thousands)            
Three and Six Months Ended June 30, 2023            
          Accumulated  
      Additional    Other  
  Ordinary Shares Paid-In Accumulated  Comprehensive Total
  Number of shares  Par Value Capital deficit Loss Equity
Balance as of December 31, 2022  67,086  $187  $3,048,915  $(2,076,852 $(12,818 $959,432 
Issuance of shares in connection with stock-based compensation plans  1,017   3   1   
-
   
-
   4 
Stock-based compensation  -   
-
   8,241   
-
   
-
   8,241 
Comprehensive loss  -   
-
   
-
   (22,224  (990  (23,214
Balance as of March 31, 2023  68,103  $190  $3,057,157  $(2,099,076 $(13,808 $944,463 
Issuance of shares in connection with stock-based compensation plans   268   1   4   
-
   
-
   5 
Stock-based compensation   -   
-
   8,022   
-
   
-
   8,022 
Comprehensive income (loss)   -   
-
   
-
   (38,615  1,137   (37,478
Issuance of Common stock under employee stock purchase plan   253   1   3,013         3,014 
Issuance of shares as part of the Covestro acquisition   318   1   5,200         5,201 
Balance as of June 30, 2023   68,942   193   3,073,396   (2,137,691  (12,671  923,227 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

4

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Changes in Equity      
(in thousands )            
Three and Six Months Ended June 30, 2022      
         Accumulated  
     Additional   Other  
 Ordinary SharesPaid-InAccumulated ComprehensiveTotal
 Number of shares Par ValueCapitaldeficitLossEquity
Balance as of December 31, 2021 65,677 $182 $3,012,481 $(2,047,878$(8,771$956,014 
Issuance of shares in connection with stock-based compensation plans 731  3  152  
-
  
-
  155 
Stock-based compensation -  
-
  8,533  
-
  
-
  8,533 
Comprehensive loss -  
-
  
-
  (20,948 (1,053 (22,001
Balance as of March 31, 2022 66,408  185  3,021,166   (2,068,826 (9,824 942,701 
Issuance of shares in connection with stock-based compensation plans 336  1  91  
-
  
-
  92 
Stock-based compensation - $
-
 $8,831 $
-
 $
-
 $8,831 
Comprehensive loss -  
-
  
-
  (24,385 (3,530 (27,915
Balance as of June 30, 2022 66,744  186  3,030,088  (2,093,211 (13,354 923,709 
 The accompanying notes are an integral part of these condensed consolidated interim financial statements.
5

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Cash Flows     
in thousands  Six Months Ended June 30,
   2023   2022 
Cash flows from operating activities     
Net loss  $(60,839 $(45,333
      
Adjustments to reconcile net loss to net cash used in operating activities:     
Impairment of other long-lived assets    919   3,865 
Depreciation and amortization   24,343   29,924 
Stock-based compensation   16,263   17,364 
Foreign currency transaction loss   1,967   10,318 
Share in losses of associated companies   7,343   174 
Revaluation of investments   1,217   2,316 
Other non-cash items, net   2,073   168 
      
Change in cash attributable to changes in operating assets and liabilities:     
Accounts receivable, net   (11,156  (11,058
Inventories   (11,161  (39,162
Other current assets and prepaid expenses   (3,777  5,320 
Other non-current assets   4,642   382 
Accounts payable   (4,360  10,217 
Other current liabilities   (8,972  (20,650
Deferred revenues   3,715   4,540 
Deferred income taxes, net and uncertain tax positions   2,810   (1,674
Other non-current liabilities   (6,194  (5,620
Net cash used in operating activities   (41,167  (38,909
      
Cash flows from investing activities      
Cash paid for acquisitions, net of cash acquired   (66,472  
-
 
Purchase of property and equipment   (6,546  (7,526
Investments in short-term bank deposits   (12,448  (195,429
Proceeds from short-term bank deposits   128,815   272,000 
Purchase of intangible assets   (464  (965
Other investing activities   (58  122 
Investments in unconsolidated entities   (6,199  (5,030
Net cash provided by investing activities   36,628   63,172 
      
Cash flows from financing activities      
Proceeds from exercise of stock options   9   247 
Payment of contingent consideration   (691  (1,386
Other financing activities   -   275 
Net cash used in financing activities   (682  (864
     
Effect of exchange rate changes on cash, cash equivalents and restricted cash   (824  (7,413
      
Net change in cash, cash equivalents and restricted cash   (6,045  15,986 
Cash, cash equivalents and restricted cash, beginning of period   150,686   243,293 
Cash, cash equivalents and restricted cash, end of period  $144,641  $259,279 
      
Supplemental disclosures of cash flow information:      
Non-cash investing and financing activities       
Transfer of inventory to fixed assets   5,612   1,150 
Transfer of fixed assets to inventory   118   123 
Issuance of Common stock under employee stock purchase plan   3,014    
Issuance of shares as part of Covestro acquisition (Refer to Note 3)   5,201    
Contingent consideration   3,009    
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:       
Cash and cash equivalents   144,366   255,886 
Restricted cash included in other current assets    275    160 
Cash balances classified as Held for sale   
-
   3,233 
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows  $144,641  $259,279 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

6

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 1. Business Description and Basis of Presentation

 Stratasys Ltd. (collectively with its subsidiaries, the “Company” or “Stratasys”) is a global leader in connected, polymer-based 3D printing solutions, across the entire manufacturing value chain. The Company leverages its competitive advantages, which include a broad set of best-in-class 3D printing platforms, software, a materials and technology partner ecosystem, innovative leadership, and global GTM infrastructure, in order to position itself to capture share in a significant and growing global marketplace, with a focus on manufacturing, which the Company views as having the largest and fastest growing total addressable market. The Company’s approximately 2,400 granted and pending additive technology patents to date have been used to create models, prototypes, manufacturing tools, and production parts for a multitude of industries including aerospace, automotive, transportation, healthcare, consumer products, dental, medical, fashion and education. Stratasys’ products and comprehensive solutions improve product quality, development time, cost, time-to-market and patient care. The Company’s 3D ecosystem of solutions and expertise includes 3D printers, materials, software, expert services, and on-demand parts production.
The condensed consolidated interim financial information herein is unaudited; however, such information reflects all adjustments (consisting of normal, recurring adjustments), which are, in the opinion of management, necessary for a fair statement of results for the interim period. The condensed consolidated interim financial statements include the accounts of Stratasys Ltd. and its subsidiaries. All intercompany accounts and transactions, including profits from intercompany sales not yet realized outside the Company, have been eliminated in consolidation.
The Company’s financial statements are prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), which require the Company to make estimates based on assumptions about current and, for some estimates, future economic and market conditions which affect reported amounts and related disclosures in its financial statements. Although the Company’s current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from the Company’s expectations, which could materially affect its results of operations and financial position.
In particular, a number of estimates have been and will continue to be affected by global events and other longer-term macroeconomic conditions, most prominently, the extent and speed at which inflation subsides, whether interest rate hikes continue, tighter credit markets and whether capital markets and global supply chains fully recover. As a result, the accounting estimates and assumptions may change over time. Such changes could have an additional impact on the Company’s long-lived asset and intangible asset valuation; and the allowance for expected credit losses. These consolidated financial statements reflect the financial statement effects based upon management’s estimates and assumptions utilizing the most currently available information. 

The results of operations for the six and three months periods ended June 30, 2023 are not necessarily indicative of results that could be expected for the entire fiscal year. Certain financial information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. The reader is referred to the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 3, 2023 as part of the Company’s Annual Report on Form 20-F for such year.

Note 2. New Accounting Pronouncements

       Accounting Pronouncements Adopted in 2023

       In October 2021, the Financial Accounting Standards Board (the FASB) issued Accounting Standards Update (ASU) 2021-08 “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. The guidance will result in the acquiree. recognizing contract assets and contract liabilities at the same amounts recorded by the acquire. The guidance should be applied prospectively to acquisitions occurring on or after the effective date. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2023, with no material impact on its consolidated financial statements.
 
7

STRATASYS LTD.
NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)
 
Note 3. Certain Transactions
 
      MakerBot and Ultimaker transaction ("Ultimaker")
On August 31, 2022, Stratasys completed the merger of MakerBot (previously, a fully owned subsidiary) with Ultimaker, which together formed a new entity under the name Ultimaker. The Company recorded a net gain of $39.1 million from deconsolidation of MakerBot, representing the difference between the book value of MakerBot's net assets and the fair value allocated to such net assets in the transaction as follows:
  U.S. $ in thousands
Fair Value, net $55,751 
Net assets deconsolidated  (14,146
Transaction expenses  (2,469
Gain on deconsolidation of subsidiary $39,136 
The Company accounts for its investment in the combined company Ultimaker according to the equity method in accordance with ASC Topic 323, as it has retained the ability to exercise significant influence but does not control the new entity. The Company recognized an equity method investment in a total amount of $105.6 million comprised of the assumed fair value of the MakerBot shares and additional amount invested in cash by the Company, representing a 46.5% share in the new entity.
The preliminary allocation of the purchase price (PPA) to the underlying net assets acquired and liability assumed resulted in the recognition of intangible assets with a value of $57.8 million, goodwill of $22.3 million and other net assets of $25.5 million. The value assigned to intangible assets is amortized over a period of 5 to 10 years and the related amortization is included under share in net losses (profits) from associated companies. The estimated fair values are preliminary and based on the information that was available as of August 31, 2022. Thus, the measurements of fair value reflected in these assets are subject to changes and such changes could be significant.
 
       As of June 30, 2023 and December 31, 2022 the equity investment in Ultimaker amounted to $92.9 million and $100.2 million, respectively, which represented the original investment in Ultimaker, net of share in net losses for the respective periods (the six months ended June 30, 2023 and year ended December 31, 2022) in amounts of $7.3 million and $5.4 million, respectively. Following the acquisition, the Company will act as an agent to Ultimaker and will distribute products of Ultimaker. Transactions with Ultimaker for the period were immaterial.
8

STRATASYS LTD.
NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)
Covestro AG assets acquisition
On April 3th, 2023 (the "Covestro transaction date"), the Company completed a definitive agreement to acquire the additive manufacturing materials business of Covestro AG.  Covestro’s additive manufacturing business is expected to give the Company the ability to accelerate innovative developments in 3D printing materials and to thereby further grow adoption of its newest technologies. Also, the Company acquired an IP portfolio comprised of hundreds of patents and pending patents, including all of the SOMOS™ portfolio.
The Covestro transaction is reflected in accordance with ASC Topic 805, “Business Combinations”. The assets acquisition transaction meets the definition of a business and was accounted for as a “Business Combinations” transaction, using the acquisition method of accounting with the Company as the acquirer. The following table summarizes the fair value of the consideration transferred to Covestro AG for the Covestro transaction:
  U.S. $ in thousands
Cash payments* $53,300 
Issuance of ordinary shares to Covestro stockholders  5,201 
Contingent consideration at estimated fair value  659 
Total consideration $59,160 
*Of which $50 million was paid on April 3, 2023.
The fair value of the ordinary shares issued was determined based on the closing market price of the Company's ordinary shares on the Covestro transaction date.
 In accordance with ASC Topic 805, the estimated contingent consideration as of the Covestro transaction date was included in the purchase price. The total contingent payments could reach to a maximum aggregate amount of up to $37 million. The payment will be settled through the issuance of ordinary shares. The estimated fair value of the contingent consideration is based on management’s assessment of whether, and at what level, the financial metrics will be achieved, and the present value factors associated with the timing of the payments. This fair value measurement is based on significant unobservable inputs in the market and thus represents a Level 3 measurement within the fair value hierarchy. Changes in the fair value of contingent consideration will be recorded in operating expenses. Refer to note 9.
9

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Covestro transaction date. The estimated fair values are preliminary and based on the information that was available as of April 3, 2023. Thus, the measurements of fair value reflected are subject to changes and such changes could be significant. The preliminary allocation of the purchase price to assets acquired and liabilities assumed is as follows:
  Allocation of Purchase Price
  (U.S. $ in thousands)
Inventory $10,429 
Fixed assets  5,043 
Goodwill  23,092 
Intangible assets  22,437 
Total assets acquired  61,001 
   
   
Other current liabilities  1,841 
Total liabilities assumed  1,841 
   
Net assets acquired $59,160 
The preliminary allocation of the PPA to net assets acquired and liability assumed resulted in the recognition of intangible assets related to developed technology, customer relationship, and trade name. These intangible assets have a useful life of 7 to 10 years. The fair value estimate of the intangible assets is determined using a variation of the income approach known as the “Multi-Period Excess Earnings Approach”. This valuation technique estimates the fair value of an asset based on market participants’ expectations of the cash flows assets would generate over its remaining useful life. The net cash flows were discounted to present value.
 Pro forma information giving effect to the acquisition has not been provided as the results would not be material.
 
      Other investments
      In addition to the investment in Ultimaker, other investments included under Long-term investments primarily consist of investments in non-marketable equity securities of several companies without readily determinable fair value in which the Company does not have a controlling interest or significant influence. During the six months ended June 30, 2023 and during 2022, the Company invested a total of $5.4 million and $16.7 million, respectively, in non-marketable equity securities and convertible notes of several companies.
10

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 4. Recent developments

Prospective Merger with Desktop Metal
 
On May 25, 2023, the Company and Desktop Metal, Inc., (“Desktop Metal”), jointly announced their entry into a merger agreement, whereby a wholly-owned Delaware subsidiary of the company will merge with and into Desktop Metal, with Desktop Metal surviving the merger as a wholly-owned subsidiary of the Company. The Company’s shareholders and Desktop Metal’s stockholders would hold 59% and 41%, respectively, of Stratasys ordinary shares following the merger. The parties expect the transaction to close in the fourth quarter of 2023, subject to the receipt of required regulatory approvals, as well as approvals of the shareholders of Stratasys and stockholders of Desktop Metal, and other customary closing conditions.
 
Nano Dimension Tender Offer and Board Contest
 
On May 25, 2023, following the announcement of the merger with Desktop Metal, Nano Dimension Ltd., (“Nano”), a 14.1% shareholder of the Company in the 3D printing industry, launched a hostile partial tender offer whereby it sought to acquire—including shares already held by it— between 53% and 55% of the Company’s outstanding ordinary shares, at a price of $18.00 per share. The tender offer was subject to various conditions and was originally set to expire on June 26, 2023. Over the course of subsequent periods of time, the price offered by Nano in its tender offer was ultimately raised to $25.00 per share, with an accompanying reduction as to the percentage of Company shares to be held by it upon consummation of the offer, to between 46% and 51%, and the offer was extended ultimately through July 31, 2023. The offer expired on July 31, 2023 and Nano did not receive enough tendered shares and was therefore unable to complete the purchase of any of the Company ordinary shares pursuant to the offer.  
 
The Company has also been subject to litigation with Nano in an Israeli district court regarding our shareholder rights plan, Nano’s tender offer, and the contested board election. The litigation has not changed the outcome of any of the developments described above. Please see note 13.
 3D Systems Offers
On May 30, 2023, and then again on June 27, 2023, the Company received an unsolicited non-binding indicative proposal from 3D Systems Corporation (“3D Systems”) to merge with the Company. The price offered was $7.50 in cash and 1.2507 shares of common stock of 3D Systems per ordinary share of Stratasys, followed by $7.50 in cash and 1.3223 shares of common stock, in those respective offers. On July 13, 2023, the Company received an updated proposal from 3D Systems, pursuant to which it would merge with the Company for $7.50 in cash and 1.5444 newly issued shares of common stock of 3D Systems per Stratasys ordinary share. The Stratasys board determined that the latest 3D Systems proposal would reasonably be expected to result in a “Superior Proposal” under the merger agreement with Desktop Metal and authorized Company management to enter into discussions with 3D Systems with respect to the proposal.
11

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 5. Revenues

Disaggregation of Revenues

The following table presents the Company’s revenues disaggregated by geographical region (based on the Company's customers' locations) and revenue type for the three and six months ended June 30, 2023 and 2022:

 Three months ended June 30,Six months ended June 30,
  2023  2022 2023 2022
 (U.S. $ in thousands)(U.S. $ in thousands)
Americas        
Systems$28,975  $32,868 $50,161 $61,850 
Consumables 33,757   34,662  66,329  66,016 
Service 39,463   39,695  75,785  77,926 
Total Americas 102,195   107,225  192,275  205,792 
         
EMEA        
Systems 12,054   14,760  23,456  29,837 
Consumables 17,910   14,268  36,821  32,093 
Service 6,920   6,184  14,487  13,337 
Total EMEA 36,884   35,212  74,764  75,267 
         
Asia Pacific        
Systems 7,284   11,235  15,148  21,693 
Consumables 9,132   7,928  18,168  17,305 
Service 4,256   5,003  8,773  9,975 
Total Asia Pacific 20,672   24,166  42,089  48,973 
         
Total Revenues$159,751  $166,603 $309,128 $330,032 

The following table presents the Company’s revenues disaggregated based on the timing of revenue recognition (at a specific point in time or over the course of time) for the three and six months ended June 30, 2023 and 2022:

 Three months ended June 30, Six months ended June 30,
  2023   2022   2023   2022 
 (U.S. $ in thousands) (U.S. $ in thousands)
Revenues recognized in point in time from:       
Products$109,112  $115,721  $210,083  $228,794 
Services 14,156   13,147   27,847   25,639 
Total revenues recognized in point in time 123,268   128,868   237,930   254,433 
        
Revenues recognized over time from:       
Services 36,483   37,735   71,198   75,599 
Total revenues recognized over time 36,483   37,735   71,198   75,599 
        
Total Revenues$159,751  $166,603  $309,128  $330,032 
12

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Contract Assets and Contract Liabilities

Contract assets are recorded when the Company's right to consideration is conditional on constraints other than the passage of time. The Company had no material contract assets as of June 30, 2023 and December 31, 2022.

Contract liabilities include advance payments and billings in excess of revenue recognized, which are primarily related to advanced billings for service type warranty. Contract liabilities are presented under deferred revenue. The Company's deferred revenue as of June 30, 2023 and December 31, 2022 were as follows:

 June 30, 2023 December 31, 2022
 U.S. $ in thousands
Deferred revenue*$79,264  $75,434 

*Includes $27.4 million and $25.2 million under long-term deferred revenue in the Company's consolidated balance sheets as of June 30, 2023 and December 31, 2022, respectively.

Revenue recognized in 2023 that was included in deferred revenue balance as of December 31, 2022 was $11.8 million and $27.9 million for the three and six months ended June 30, 2023.

Remaining Performance Obligations

Remaining Performance Obligations (RPO) represent contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of June 30, 2023, the total RPO amounted to $107.4 million. The Company expects to recognize $78.7 million of this RPO during the next 12 months, $14.3 million over the subsequent 12 months and the remaining $14.4 million thereafter.

Incremental Costs of Obtaining a Contract

Sales commissions earned mainly by the Company’s sales agents are considered incremental costs of obtaining a contract with a customer, as the Company expects the benefit of those commissions to be longer than one year. The majority of the sales commissions are not subject to capitalization, as the commission expense is recognized as the related revenue is recognized. Sales commissions for initial contracts related to the service type warranty are deferred and then amortized on a straight-line basis over the expected customer relationship period if the Company expects to recover those costs. Amortization expense is included in selling, general and administrative expenses in the consolidated statements of operations and comprehensive loss. As of June 30, 2023 and December 31, 2022, the deferred commissions amounted to $9.7 million and $9.6 million, respectively.

13

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 6. Inventories

Inventories consisted of the following as of the below balance sheet dates:

 June 30, 2023 December 31, 2022
 U.S. $ in thousands
Finished goods$88,967  $81,564 
Work-in-process 11,429   7,562 
Raw materials 110,790   104,928 
 $211,186  $194,054 

Note 7. Goodwill and Other Intangible Assets

       Goodwill

Changes in the carrying amount of the Company’s goodwill during the six months ended June 30, 2023 were as follows:
  U.S. $ in thousands
   
Goodwill as of January 1, 2023 $64,953 
Goodwill acquired  27,835 
Foreign currency translation adjustments  158 
Goodwill as of June 30, 2023 $92,946 
       
14

STRATASYS LTD.
NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)
   

       Other Intangible Assets

Other intangible assets consisted of the following:

  June 30, 2023 December 31, 2022
   Carrying Amount,      Net   Carrying Amount,   Net
    Net of   Accumulated   Book   Net of Accumulated Book
    Impairment    Amortization   Value   Impairment  Amortization Value
  U.S. $ in thousands
Developed technology $406,738 $(292,135 $114,603  $387,603  $(283,671 $103,932 
Patents  17,958  (9,640  8,318   17,508   (8,970  8,538 
Trademarks and trade names  21,368  (14,776  6,592   16,278   (14,030  2,248 
Customer relationships  109,419   (90,319  19,100   93,609   (86,925  6,684 
Capitalized software development costs  7,066   (7,066  
-
   7,066   (7,066  
-
 
  $562,549  $(413,936 $148,613  $522,064 $(400,662$121,402 

Amortization expenses relating to intangible assets for the three-month periods ended June 30, 2023 and 2022 were approximately $7.1 million and $9.2 million, respectively. Amortization expenses relating to intangible assets for the six-month periods ended June 30, 2023 and 2022 were approximately $13.3 million and $18.4 million, respectively.

As of June 30, 2023, the estimated amortization expenses relating to intangible assets for each of the following future periods were as follows:

  Estimated
  amortization expenses
  (U.S. $ in thousands)
Remaining 6 months of 2023 $14,202 
2024  23,774 
2025  22,371 
2026  22,293 
2027  20,892 
2028 and thereafter  45,081 
Total $148,613 

Note 8. Net Loss Per Share

The following table presents the numerator and denominator of the basic and diluted net loss per share computations for the three and six months ended June 30, 2023 and 2022:

 Three Months Ended June 30, Six Months Ended June 30,
  2023   2022   2023   2022 
 In thousands, except per share amounts In thousands, except per share amounts
Numerator:        
Net loss for basic and diluted net loss per share
$(38,615 $(24,385 $(60,839 $(45,333
        
Denominator:        
Weighted average shares - for basic and diluted net loss per share
 68,648   66,568   68,107   66,151 
        
Net loss per share       
Basic and diluted
$(0.56 $(0.37 $(0.89 $(0.69

 The computation of diluted net loss per share excluded share awards of 3 million shares and 5.2 million shares for the three months ended June 30, 2023 and 2022 respectively, because the inclusion of those shares would have had an anti-dilutive effect on the diluted net loss per share. 

The computation of diluted net loss per share excluded share awards of 3.3 million shares and 5.2 million shares for the six months ended June 30, 2023 and 2022 respectively, because the inclusion of those shares would have had an anti-dilutive effect on the diluted net loss per share.

15

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

 

Note 9. Income Taxes

 

      The Company had income tax expense of $0.7 million for the three-month period ended June 30, 2023, compared to income tax benefit of $0.4 million for the three-month period ended June 30, 2022. The Company had income tax expense of $4.5 million for the six-month period ended June 30, 2023, compared to income tax benefit of $0.5 million for the six-month period ended June 30, 2022. The Company’s effective tax rate as of June 30, 2023, was primarily impacted by the geographic mix of its earnings and losses, movements in its valuation allowance and changes in its uncertain tax positions.

 

Note 10. Fair Value Measurements

Financial instruments measured at fair value

The following table summarizes the Company’s financial assets and liabilities that are carried at fair value on a recurring basis, in its consolidated balance sheets:

 June 30, 2023 December 31, 2022
 Level 2 Level 3 Level 2 Level 3
 (U.S. $ in thousands)
Assets:       
Foreign exchange forward contracts not designated as hedging instruments$7  $
-
  $159  $
-
 
Foreign exchange forward contracts designated as hedging instruments 376   
-
   3   
-
 
        
Liabilities:       
Foreign exchange forward contracts not designated as hedging instruments (87  
-
   (38  
-
 
Foreign exchange forward contracts designated as hedging instruments (2,540  
-
   (1,640  
-
 
Convertible notes 
-
   5,423   
-
   1,894 
Contingent consideration* 
-
   41,171   
-
   38,341 
$(2,244 $46,594  $(1,516 $40,235 
*Includes $15.0 million and $14.6 million under accrued expenses and other current liabilities in the Company's consolidated balance sheets as of June 30, 2023 and December 31, 2022, respectively.

The Company's foreign exchange forward contracts are classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs, including interest rate curves and both forward and spot prices for currencies (Level 2 inputs).

Contingent consideration represents liabilities recorded at fair value in connection with acquisitions, and thus represents a Level 3 measurement within the fair value hierarchy (refer to Note 3).

Other financial instruments consist mainly of cash and cash equivalents, short-term deposits, current and non-current receivables, accounts payable and other current liabilities. The fair value of these financial instruments approximates their carrying values.

16

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 11. Derivative instruments and hedging activities

Since the Company conducts its operations globally, it is exposed to global market risks and to the risk that its earnings, cash flows and equity could be adversely impacted by fluctuations in foreign currency exchange rates. The Company enters into transactions involving foreign currency exchange derivative financial instruments. The Company manages its foreign currency exposures on a consolidated basis, which allows the Company to net exposures and take advantage of any natural hedging. The transactions are designed to manage the Company’s net exposure to foreign currency exchange rates and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The Company does not enter into derivative transactions for trading purposes.

The Company is primarily exposed to foreign exchange risk with respect to recognized assets and liabilities and forecasted transactions denominated in the New Israeli Shekel (“NIS”), Euro, British Pound, Korean Won, Chinese Yuan and the Japanese Yen. The gains and losses on the hedging instruments partially offset losses and gains on the hedged items. Financial markets and currency volatility may limit the Company’s ability to hedge these exposures. These contracts mature through June 2023.

The following table summarizes the consolidated balance sheets classification and fair values of the Company’s derivative instruments:

    Fair Value Notional Amount
    June 30, December 31, June 30, December 31,
  Balance sheet location 2023 2022 2023 2022
    U.S. $ in thousands
Assets derivatives -Foreign exchange contracts, not designated as hedging instruments Other current assets $7  $159  $25,093  $101,733 
Assets derivatives -Foreign exchange contracts, designated as cash flow hedge Other current assets  376   3   28,221   4,900 
Liability derivatives -Foreign exchange contracts, not designated as hedging instruments Accrued expenses and other current liabilities  (87  (38  33,927   16,751 
Liability derivatives -Foreign exchange contracts, designated as hedging instruments Accrued expenses and other current liabilities  (2,540  (1,640  36,858   72,273 
    $(2,244 $(1,516 $124,099  $195,657 

Foreign exchange contracts not designated as hedging instruments

As of June 30, 2023, the notional amounts of the Company’s outstanding exchange forward contracts, not designated as hedging instruments, were $59.0 million, and were used to reduce foreign currency exposures. With respect to such derivatives, a gain of $1.6 million and a gain of $2.4 million were recognized under financial expenses, net for the three-month periods ended June 30, 2023 and 2022, respectively and a gain of $1.2 million and a gain of $3.1 million were recognized under financial expenses, net for the six-month periods ended June 30, 2023 and 2022, respectively. Such gains or losses partially offset the foreign currency revaluation changes of the balance sheet items. These foreign currencies revaluation changes are also recognized under financial income, net.

Cash Flow Hedging - Hedges of forecasted foreign currency payroll and other operating expenses

As of June 30, 2023, the Company had in effect foreign exchange forward contracts, designated as cash flow hedges for accounting purposes, for the conversion of $36.9 million into NIS. The Company uses short-term cash flow hedge contracts to reduce its exposure to variability in expected future cash flows resulting mainly from payroll costs and other operating expenses denominated in NIS. The changes in fair value of those contracts are included in the Company’s accumulated other comprehensive loss.

Cash Flow Hedging - Hedges of forecasted foreign currency revenue

As of June 30, 2023, the Company had in effect foreign exchange forward contracts, designated as cash flow hedges for accounting purposes, for the conversion of 28.2 million Euro into U.S. dollars. The Company transacts business in U.S. dollars and in various other currencies. The Company may use foreign exchange or forward contracts to hedge certain cash flow exposures resulting from changes in these foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities of up to twelve months. The Company enters into these foreign exchange contracts to hedge a portion of its forecasted foreign currency denominated revenue in the normal course of business, and accordingly, they are not speculative in nature.

17

 STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 12. Equity

a. Stock-based compensation plans

Stock-based compensation expenses for equity-classified stock options, restricted share units (“RSUs”), performance-based restricted share units (PSUs) and Employee Share Purchase Plan ("ESPP") were allocated as follows:

 Three Months Ended June 30, Six Months Ended June 30,
  2023   2022   2023   2022 
 U.S $ in thousands U.S $ in thousands
Cost of revenues$999  $1,080  $1,931  $1,980 
Research and development, net 1,867   1,606   3,956   3,392 
Selling, general and administrative 5,156   6,145   10,376   11,992 
Total stock-based compensation expenses$8,022  $8,831  $16,263  $17,364 

A summary of the Company’s stock option activity for the six months ended June 30, 2023 is as follows:

 Number of Options Weighted Average Exercise Price
Options outstanding as of January 1, 2023 1,619,559   27.62 
Granted 
-
   
-
 
Exercised (2,429  3.56 
Forfeited (205,478  64.78 
Options outstanding as of June 30, 2023 1,411,652   22.25 
Options exercisable as of June 30, 2023 1,084,689   24.18 

As of June 30, 2023, the unrecognized compensation cost of $0.9 million related to all unvested, equity-classified stock options is expected to be recognized as an expense over a weighted-average period of 1.41 years.

18

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

A summary of the Company’s RSUs and PSUs activity for the six months ended June 30, 2023 is as follows:

 Number of RSUs and PSUs Weighted Average Grant Date Fair Value
Unvested as of January 1, 2023 3,496,099   23.98 
Granted 1,784,752   13.26 
Vested (1,262,954  24.37 
Forfeited (201,832  24.15 
Unvested as of June 30, 2023 3,816,065   18.83 

The fair value of RSUs and PSUs is determined based on the quoted price of the Company’s ordinary shares on the date of the grant.

As of June 30, 2023, the unrecognized compensation cost of $57.60 million related to all unvested, equity-classified RSUs and PSUs is expected to be recognized as expense over a weighted-average period of 2.72 years.

Employee Stock Purchase Plan

On October 2021, the Company adopted the 2021 Employee Stock Purchase Plan (the “ESPP”). According to the ESPP, eligible employees may use up to 15% of their salaries to purchase ordinary shares. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the beginning of each offering period or on the purchase date. The first offering period commenced on June 1, 2022 and ended on November 30, 2022, the second offering commenced on December 1,2022 and ended on May 31, 2023 and the third offering commenced on June 1, 2023 and will end on November 30, 2023. 

In accordance with ASC Topic 718, the ESPP is considered compensatory and, as such, results in recognition of stock-based compensation expenses.

b. Accumulated other comprehensive loss

The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the six months ended June 30, 2023 and 2022, respectively:

 Six Months Ended June 30, 2023
 Net Unrealized Gain (Loss) on Cash Flow Hedges Foreign Currency Translation Adjustments Total
 U.S. $ in thousands
      
Balance as of January 1, 2023$(299 $(12,519 $(12,818
Other comprehensive income (loss) before reclassifications (2,708  1,834   (874
Amounts reclassified from accumulated other comprehensive loss 1,021   
-
   1,021 
Other comprehensive loss (1,687  1,834   147 
Balance as of June 30, 2023$(1,986 $(10,685 $(12,671
 Six Months Ended June 30, 2022
 Net Unrealized Gain (Loss) on Cash Flow Hedges Foreign Currency Translation Adjustments Total
 U.S. $ in thousands
      
Balance as of January 1, 2022$1,572  $(10,343 $(8,771
Other comprehensive income before reclassifications (1,049  (3,491  (4,540
Amounts reclassified from accumulated other comprehensive loss (43  
-
   (43
Other comprehensive income (1,092  (3,491  (4,583
Balance as of June 30, 2022$480  $(13,834 $(13,354
19

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

 
c. Rights plan

On July 24, 2022, the Company’s Board of Directors adopted a shareholder rights plan (the “Rights Plan”) to protect the interests of the Company’s shareholders. Each Right entitles the registered holder thereof to purchase from the Company one ordinary share, par value NIS 0.01, of the Company (“ordinary share”) at a price of $0.01 per share, subject to adjustment, once the Rights become exercisable, and subject to the exercise terms and conditions thereof described in the agreement governing the Rights Plan (the “Rights Agreement”). The rights would become exercisable only if an entity, person, or group acquires beneficial ownership of 15% or more of the Company’s outstanding ordinary shares in a transaction not approved by the Company’s Board. The Rights Plan originally had a 364-day term, expiring on July 24, 2023. On May 25, 2023, in connection with the execution and delivery on that day of the agreement and plan of merger, by and among Stratasys, Desktop Metal, Inc., and Tetris Sub Inc., a Delaware corporation and Stratasys’ wholly-owned subsidiary (the “Desktop Metal Merger Agreement”), Stratasys entered into an amendment to the Rights Agreement with the rights agent. The amendment extended the expiration date of the Rights Agreement to the later of (a) July 24, 2023 and (b) the conclusion of Stratasys’ shareholder meeting (or, if adjourned, the conclusion of the reconvened meeting) at which the merger under the Desktop Metal Merger Agreement would be brought for approval, or such time as the Desktop Metal Merger Agreement has been terminated in accordance with its terms. 

The adoption of the Rights Plan is intended to protect the long-term interests of Stratasys and all Stratasys shareholders. The Rights Plan is designed to reduce the likelihood that any entity, person, or group would gain control of, or significant influence over, Stratasys through the open-market accumulation of the Company’s shares without appropriately compensating all Stratasys shareholders for control. The Rights Plan will encourage anyone seeking to gain a significant interest in Stratasys to negotiate directly with the Board prior to attempting to control or significantly influence the Company. Further to those goals, the Rights may cause substantial dilution to a person or group that acquires 15% or more of the ordinary shares or any existing holder of 15% or more of the ordinary shares who shall acquire any additional ordinary shares.

 

Note 13. Contingencies

Legal proceedings

 
Litigation with Nano Dimension regarding Stratasys’ Rights Plan, Nano Dimension’s tender offer, and Stratasys board election
 
On April 25, 2023, the Company was named as a defendant in an action filed by Nano in the Tel-Aviv District Court in which Nano sought declaratory relief declaring that Stratasys’ shareholder rights plan is both illegal and void, and also requested a court order enjoining the Company and its directors from intervening with, or hindering in any way, a tender offer that Nano at the time intended to launch to acquire Stratasys ordinary shares.
 
On June 8, 2023, in its statement of defense, the Company rejected all of Nano’s claims, stating, among other things, that there was a substantial change of circumstance since Nano’s action was filed due to Stratasys’ entry into the Desktop Metal Merger Agreement on May 25, 2023 and the launch of Nano’s tender offer on May 25, 2023. The Company argued that its rights plan is legal under Israeli law, and that due to the many flaws and unlawful conditions of Nano’s tender offer and Nano’s conduct and circumstances, The Company’s board was obligated to get involved and protect the Company and its shareholders. The Company also submitted a counterclaim to the court, seeking an order restraining Nano from completing its tender offer until certain conditions were to be fulfilled.
 
On July 18, 2023, in the context of an interim procedural decision, the Israeli court took the opportunity to express its preliminary view on the legality of shareholder rights plans for Israeli companies. The court indicated that it is inclined to view rights plans as permissible under Israeli law; that the adoption of a rights plan by a board should be viewed “with suspicion”; and that the board would bear the burden of proving certain matters related to the adoption of such a plan.
 
The court has set a schedule for submission of written summations by the parties, with Nano to submit its summations as claimant by August 7, 2023, the Company to submit its summations as respondent and counterclaimant by August 25, 2023, and Nano to submit its summations as counter-respondent by September 14, 2023.
 
In a separate action, on July 13, 2023, Nano filed a motion in an Israeli court requesting that the court order, among other things, that (i) The Company correct the agenda sent out to its shareholders in advance of an annual general shareholder meeting scheduled for August 8, 2023, so that the agenda would include Nano’s individual director nominees for the Company’s board, and (ii) The Company issue a new proxy statement and proxy card for the annual general shareholder meeting.
 
On July 28, 2023, Nano issued a press release in which it announced that it intends to withdraw its nominees for the Company’s board, which Nano reiterated in a press release that it issued on August 1, 2023.
Ordinary course litigation
In addition to the foregoing litigations, the Company is also a party to various legal proceedings from time to time, the outcome of which, in the opinion of management, will not have a significant effect on the financial position, profitability or cash flows of the Company.
     
20

 
0.37 0.56 0.69 0.89 66151 66568 68107 68648 24385000 38615000 45333000 60839000 66151 66568 68107 68648 0.37 0.56 0.69 0.89 false --12-31 Q2 2023-06-30 0001517396 0001517396 2023-01-01 2023-06-30 0001517396 2023-06-30 0001517396 2022-12-31 0001517396 us-gaap:ProductMember 2023-04-01 2023-06-30 0001517396 us-gaap:ProductMember 2022-04-01 2022-06-30 0001517396 us-gaap:ProductMember 2023-01-01 2023-06-30 0001517396 us-gaap:ProductMember 2022-01-01 2022-06-30 0001517396 us-gaap:ServiceMember 2023-04-01 2023-06-30 0001517396 us-gaap:ServiceMember 2022-04-01 2022-06-30 0001517396 us-gaap:ServiceMember 2023-01-01 2023-06-30 0001517396 us-gaap:ServiceMember 2022-01-01 2022-06-30 0001517396 2023-04-01 2023-06-30 0001517396 2022-04-01 2022-06-30 0001517396 2022-01-01 2022-06-30 0001517396 us-gaap:CommonStockMember 2022-12-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001517396 us-gaap:RetainedEarningsMember 2022-12-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001517396 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001517396 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001517396 2023-01-01 2023-03-31 0001517396 us-gaap:CommonStockMember 2023-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001517396 us-gaap:RetainedEarningsMember 2023-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001517396 2023-03-31 0001517396 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001517396 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001517396 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001517396 us-gaap:CommonStockMember 2023-06-30 0001517396 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001517396 us-gaap:RetainedEarningsMember 2023-06-30 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001517396 us-gaap:CommonStockMember 2021-12-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001517396 us-gaap:RetainedEarningsMember 2021-12-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001517396 2021-12-31 0001517396 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001517396 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001517396 2022-01-01 2022-03-31 0001517396 us-gaap:CommonStockMember 2022-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001517396 us-gaap:RetainedEarningsMember 2022-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001517396 2022-03-31 0001517396 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001517396 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001517396 us-gaap:CommonStockMember 2022-06-30 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001517396 us-gaap:RetainedEarningsMember 2022-06-30 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001517396 2022-06-30 0001517396 ssys:BusinessCombinationMember 2023-01-01 2023-06-30 0001517396 ssys:MakerBotMember 2022-08-01 2022-08-31 0001517396 srt:MinimumMember ssys:PPAMember 2023-06-30 0001517396 srt:MaximumMember ssys:PPAMember 2023-06-30 0001517396 2022-01-01 2022-12-31 0001517396 2023-04-01 2023-04-03 0001517396 srt:MinimumMember 2023-06-30 0001517396 srt:MaximumMember 2023-06-30 0001517396 srt:MaximumMember 2023-05-01 2023-05-25 0001517396 srt:MinimumMember 2023-05-01 2023-05-25 0001517396 ssys:NanoDimensionLtdMember 2023-05-01 2023-05-25 0001517396 srt:MinimumMember ssys:NanoDimensionLtdMember 2023-05-01 2023-05-25 0001517396 srt:MaximumMember ssys:NanoDimensionLtdMember 2023-05-01 2023-05-25 0001517396 ssys:NanoDimensionLtdMember 2023-05-25 0001517396 ssys:NanoDimensionLtdMember 2023-06-26 0001517396 srt:MinimumMember ssys:NanoDimensionLtdMember 2023-06-01 2023-06-26 0001517396 srt:MaximumMember ssys:NanoDimensionLtdMember 2023-06-01 2023-06-26 0001517396 ssys:ThreeDSystemsMember 2023-05-30 0001517396 2023-05-30 0001517396 ssys:ThreeDSystemsMember us-gaap:SubsequentEventMember 2023-07-13 0001517396 ssys:SystemsMember srt:AmericasMember 2023-04-01 2023-06-30 0001517396 ssys:SystemsMember srt:AmericasMember 2022-04-01 2022-06-30 0001517396 ssys:SystemsMember srt:AmericasMember 2023-01-01 2023-06-30 0001517396 ssys:SystemsMember srt:AmericasMember 2022-01-01 2022-06-30 0001517396 ssys:ConsumablesMember srt:AmericasMember 2023-04-01 2023-06-30 0001517396 ssys:ConsumablesMember srt:AmericasMember 2022-04-01 2022-06-30 0001517396 ssys:ConsumablesMember srt:AmericasMember 2023-01-01 2023-06-30 0001517396 ssys:ConsumablesMember srt:AmericasMember 2022-01-01 2022-06-30 0001517396 us-gaap:ServiceMember srt:AmericasMember 2023-04-01 2023-06-30 0001517396 us-gaap:ServiceMember srt:AmericasMember 2022-04-01 2022-06-30 0001517396 us-gaap:ServiceMember srt:AmericasMember 2023-01-01 2023-06-30 0001517396 us-gaap:ServiceMember srt:AmericasMember 2022-01-01 2022-06-30 0001517396 srt:AmericasMember 2023-04-01 2023-06-30 0001517396 srt:AmericasMember 2022-04-01 2022-06-30 0001517396 srt:AmericasMember 2023-01-01 2023-06-30 0001517396 srt:AmericasMember 2022-01-01 2022-06-30 0001517396 ssys:SystemsMember us-gaap:EMEAMember 2023-04-01 2023-06-30 0001517396 ssys:SystemsMember us-gaap:EMEAMember 2022-04-01 2022-06-30 0001517396 ssys:SystemsMember us-gaap:EMEAMember 2023-01-01 2023-06-30 0001517396 ssys:SystemsMember us-gaap:EMEAMember 2022-01-01 2022-06-30 0001517396 ssys:ConsumablesMember us-gaap:EMEAMember 2023-04-01 2023-06-30 0001517396 ssys:ConsumablesMember us-gaap:EMEAMember 2022-04-01 2022-06-30 0001517396 ssys:ConsumablesMember us-gaap:EMEAMember 2023-01-01 2023-06-30 0001517396 ssys:ConsumablesMember us-gaap:EMEAMember 2022-01-01 2022-06-30 0001517396 us-gaap:ServiceMember us-gaap:EMEAMember 2023-04-01 2023-06-30 0001517396 us-gaap:ServiceMember us-gaap:EMEAMember 2022-04-01 2022-06-30 0001517396 us-gaap:ServiceMember us-gaap:EMEAMember 2023-01-01 2023-06-30 0001517396 us-gaap:ServiceMember us-gaap:EMEAMember 2022-01-01 2022-06-30 0001517396 us-gaap:EMEAMember 2023-04-01 2023-06-30 0001517396 us-gaap:EMEAMember 2022-04-01 2022-06-30 0001517396 us-gaap:EMEAMember 2023-01-01 2023-06-30 0001517396 us-gaap:EMEAMember 2022-01-01 2022-06-30 0001517396 ssys:SystemsMember srt:AsiaPacificMember 2023-04-01 2023-06-30 0001517396 ssys:SystemsMember srt:AsiaPacificMember 2022-04-01 2022-06-30 0001517396 ssys:SystemsMember srt:AsiaPacificMember 2023-01-01 2023-06-30 0001517396 ssys:SystemsMember srt:AsiaPacificMember 2022-01-01 2022-06-30 0001517396 ssys:ConsumablesMember srt:AsiaPacificMember 2023-04-01 2023-06-30 0001517396 ssys:ConsumablesMember srt:AsiaPacificMember 2022-04-01 2022-06-30 0001517396 ssys:ConsumablesMember srt:AsiaPacificMember 2023-01-01 2023-06-30 0001517396 ssys:ConsumablesMember srt:AsiaPacificMember 2022-01-01 2022-06-30 0001517396 us-gaap:ServiceMember srt:AsiaPacificMember 2023-04-01 2023-06-30 0001517396 us-gaap:ServiceMember srt:AsiaPacificMember 2022-04-01 2022-06-30 0001517396 us-gaap:ServiceMember srt:AsiaPacificMember 2023-01-01 2023-06-30 0001517396 us-gaap:ServiceMember srt:AsiaPacificMember 2022-01-01 2022-06-30 0001517396 srt:AsiaPacificMember 2023-04-01 2023-06-30 0001517396 srt:AsiaPacificMember 2022-04-01 2022-06-30 0001517396 srt:AsiaPacificMember 2023-01-01 2023-06-30 0001517396 srt:AsiaPacificMember 2022-01-01 2022-06-30 0001517396 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2023-04-01 2023-06-30 0001517396 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-04-01 2022-06-30 0001517396 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-06-30 0001517396 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2023-04-01 2023-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-04-01 2022-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-06-30 0001517396 us-gaap:TransferredAtPointInTimeMember 2023-04-01 2023-06-30 0001517396 us-gaap:TransferredAtPointInTimeMember 2022-04-01 2022-06-30 0001517396 us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-06-30 0001517396 us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2023-04-01 2023-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-04-01 2022-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2023-01-01 2023-06-30 0001517396 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-06-30 0001517396 us-gaap:TransferredOverTimeMember 2023-04-01 2023-06-30 0001517396 us-gaap:TransferredOverTimeMember 2022-04-01 2022-06-30 0001517396 us-gaap:TransferredOverTimeMember 2023-01-01 2023-06-30 0001517396 us-gaap:TransferredOverTimeMember 2022-01-01 2022-06-30 0001517396 us-gaap:GoodwillMember 2022-12-31 0001517396 us-gaap:GoodwillMember 2023-01-01 2023-06-30 0001517396 us-gaap:GoodwillMember 2023-06-30 0001517396 us-gaap:DevelopedTechnologyRightsMember 2023-06-30 0001517396 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001517396 us-gaap:PatentsMember 2023-06-30 0001517396 us-gaap:PatentsMember 2022-12-31 0001517396 us-gaap:TrademarksAndTradeNamesMember 2023-06-30 0001517396 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001517396 us-gaap:CustomerRelationshipsMember 2023-06-30 0001517396 us-gaap:CustomerRelationshipsMember 2022-12-31 0001517396 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-06-30 0001517396 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel2Member 2023-06-30 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2023-06-30 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:MeasurementInputConversionPriceMember 2023-06-30 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember ssys:MeasurementInputConversionOfPriceMember 2023-06-30 0001517396 us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2023-06-30 0001517396 us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2023-06-30 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:NondesignatedMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2023-06-30 0001517396 us-gaap:NondesignatedMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2023-06-30 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:EmployeeStockOptionMember 2023-06-30 0001517396 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001517396 ssys:RestrictedAndPhantomShareUnitsMember 2023-06-30 0001517396 ssys:RestrictedAndPhantomShareUnitsMember 2023-01-01 2023-06-30 0001517396 2021-10-01 2021-10-31 0001517396 2021-07-24 0001517396 2021-07-01 2021-07-24 0001517396 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001517396 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001517396 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001517396 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001517396 us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-01 2023-06-30 0001517396 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001517396 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-06-30 0001517396 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001517396 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001517396 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001517396 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001517396 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001517396 ssys:StockbasedCompensationPlansMember 2023-04-01 2023-06-30 0001517396 ssys:StockbasedCompensationPlansMember 2022-04-01 2022-06-30 0001517396 ssys:StockbasedCompensationPlansMember 2023-01-01 2023-06-30 0001517396 ssys:StockbasedCompensationPlansMember 2022-01-01 2022-06-30 0001517396 ssys:RestrictedAndPhantomShareUnitsMember 2022-12-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-06-30 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-06-30 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-06-30 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-06-30 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 iso4217:USD iso4217:ILS xbrli:shares xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:ILS iso4217:EUR